![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 50, 48523-48534, December 13, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Mammals contain 9-10 secreted phospholipases
A2 (sPLA2s) that display widely different
affinities for membranes, depending on the phospholipid composition.
The much higher enzymatic activity of human group X sPLA2
(hGX) compared with human group IIA sPLA2 (hGIIA) on
phosphatidylcholine (PC)-rich vesicles is due in large part to the
higher affinity of the former enzyme for such vesicles; this result
also holds when vesicles contain cholesterol and sphingomyelin. The
inclusion of anionic phosphatidylserine in PC vesicles
dramatically enhances interfacial binding and catalysis of hGIIA but
not of hGX. This is the result of the large number of lysine and
arginine residues scattered over the entire surface of hGIIA, which
cause the enzyme to form a supramolecular aggregate with multiple
vesicles. Thus, high affinity binding of hGIIA to anionic vesicles is a complex process and cannot be attributed to a few basic residues on its
interfacial binding surface, as is also evident from mutagenesis studies. The main reason hGIIA binds poorly to PC-rich vesicles is that
it lacks a tryptophan residue on its interfacial binding surface, a
residue that contributes to the high affinity binding of hGX to PC-rich
vesicles. Results show that the lag in the onset of hydrolysis of PC
vesicles by hGIIA is due in part to the poor affinity of this enzyme
for these vesicles. Binding affinity of hGIIA, hGX, and their mutants
to PC-rich vesicles is well correlated to the ability of these enzymes
to act on the PC-rich outer plasma membrane of mammalian cells.
On the Binding Preference of Human Groups IIA and X
Phospholipases A2 for Membranes with Anionic
Phospholipids*
§,
§,
§,
, and
§
Chemistry,
§ Biochemistry, and ¶ Physics, University of
Washington, Seattle, Washington 98195
*
This work was supported by National Institutes of Health
Grant HL36236 (to M. H. G.), a National Science Foundation
Career Award, the Petroleum Research Fund (American Chemical Society), the Royalty Research Fund (University of Washington) (to S. L. K.), and a University of Washington Center for Nanotechnology IGERT Graduate Fellowship (to S. L. V.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Depts. of
Chemistry and Biochemistry, Box 351700, University of Washington,
Seattle, WA 98195. Tel.: 206-543-7142; Fax: 206-685-8665; E-mail:
gelb@chem.washington.edu.
This article has been cited by other articles:
![]() |
A. Kuksis and W. Pruzanski Phase composition of lipoprotein SM/cholesterol/PtdCho affects FA specificity of sPLA2s J. Lipid Res., October 1, 2008; 49(10): 2161 - 2168. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Birts, C. H. Barton, and D. C. Wilton A Catalytically Independent Physiological Function for Human Acute Phase Protein Group IIA Phospholipase A2: CELLULAR UPTAKE FACILITATES CELL DEBRIS REMOVAL J. Biol. Chem., February 22, 2008; 283(8): 5034 - 5045. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Linderoth, T. L. Andresen, K. Jorgensen, R. Madsen, and G. H. Peters Molecular Basis of Phospholipase A2 Activity toward Phospholipids with sn-1 Substitutions Biophys. J., January 1, 2008; 94(1): 14 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-A. Karabina, I. Brocheriou, G. Le Naour, M. Agrapart, H. Durand, M. Gelb, G. Lambeau, and E. Ninio Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function FASEB J, December 1, 2006; 20(14): 2547 - 2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leidy, L. Linderoth, T. L. Andresen, O. G. Mouritsen, K. Jorgensen, and G. H. Peters Domain-Induced Activation of Human Phospholipase A2 Type IIA: Local versus Global Lipid Composition Biophys. J., May 1, 2006; 90(9): 3165 - 3175. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Piris-Gimenez, M. Paya, G. Lambeau, M. Chignard, M. Mock, L. Touqui, and P. L. Goossens In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax J. Immunol., November 15, 2005; 175(10): 6786 - 6791. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Qin, A. H. Pande, K. N. Nemec, X. He, and S. A. Tatulian Evidence for the Regulatory Role of the N-terminal Helix of Secretory Phospholipase A2 from Studies on Native and Chimeric Proteins J. Biol. Chem., November 4, 2005; 280(44): 36773 - 36783. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikeno, N. Konno, S.-h. Cheon, A. Bolchi, S. Ottonello, K. Kitamoto, and M. Arioka Secretory Phospholipases A2 Induce Neurite Outgrowth in PC12 Cells through Lysophosphatidylcholine Generation and Activation of G2A Receptor J. Biol. Chem., July 29, 2005; 280(30): 28044 - 28052. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Granata, A. Petraroli, E. Boilard, S. Bezzine, J. Bollinger, L. Del Vecchio, M. H. Gelb, G. Lambeau, G. Marone, and M. Triggiani Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor J. Immunol., January 1, 2005; 174(1): 464 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Mounier, F. Ghomashchi, M. R. Lindsay, S. James, A. G. Singer, R. G. Parton, and M. H. Gelb Arachidonic Acid Release from Mammalian Cells Transfected with Human Groups IIA and X Secreted Phospholipase A2 Occurs Predominantly during the Secretory Process and with the Involvement of Cytosolic Phospholipase A2-{alpha} J. Biol. Chem., June 11, 2004; 279(24): 25024 - 25038. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Stottrup, S. L. Veatch, and S. L. Keller Nonequilibrium Behavior in Supported Lipid Membranes Containing Cholesterol Biophys. J., May 1, 2004; 86(5): 2942 - 2950. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Canaan, Z. Zadori, F. Ghomashchi, J. Bollinger, M. Sadilek, M. E. Moreau, P. Tijssen, and M. H. Gelb Interfacial Enzymology of Parvovirus Phospholipases A2 J. Biol. Chem., April 9, 2004; 279(15): 14502 - 14508. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. BOILARD, S. G. BOURGOIN, C. BERNATCHEZ, P. E. POUBELLE, and M. E. SURETTE Interaction of low molecular weight group IIA phospholipase A2 with apoptotic human T cells: role of heparan sulfate proteoglycans FASEB J, June 1, 2003; 17(9): 1068 - 1080. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |